Ms Catherine Martel

Catherine Martel

Updates

Product Regulation & Liability

Superior Court refuses authorisation for class action against drug manufacturer
Canada | 18 August 2011

The Quebec Superior Court recently dismissed a motion filed by a petitioner for authorisation to institute a class action against a drug manufacturer on behalf of all natural persons in Quebec who had purchased or taken a drug marketed under the name FOSAMAX®, which is prescribed for treating and preventing osteoporosis. The petitioner accused the manufacturer of negligence and failure in its duty of safety and its duty to inform in marketing the drug.